Literature DB >> 20933468

The role of conformational ensembles of seven transmembrane receptors in functional selectivity.

Nagarajan Vaidehi1, Terry Kenakin.   

Abstract

It has been observed that some ligands cause receptors to selectively interact with subsets of signaling proteins to 'bias' their signaling; this is inconsistent with receptors forming a single active state. Here we review the concept of receptor conformation ensembles that can account for a given agonist showing varied efficacies for different signaling pathways. Data show that agonists can stabilize different receptor conformations. We provide a demonstration at the molecular level of how the various receptor conformations in the ensemble can produce functional selectivity for signaling pathways. Specifically, agonists that selectively stabilize certain receptor conformations from the ensemble can produce biased agonism towards this signaling pathway. These ideas are described with data supported from recent computations of the potential energy surface of the β2-adrenergic receptor.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933468     DOI: 10.1016/j.coph.2010.09.004

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  45 in total

1.  Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations.

Authors:  J Corey Fowler; Supriyo Bhattacharya; Jonathan D Urban; Nagarajan Vaidehi; Richard B Mailman
Journal:  Mol Pharmacol       Date:  2012-03-13       Impact factor: 4.436

Review 2.  The significance of G protein-coupled receptor crystallography for drug discovery.

Authors:  John A Salon; David T Lodowski; Krzysztof Palczewski
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 3.  Ligand-directed signalling within the opioid receptor family.

Authors:  Amynah A Pradhan; Monique L Smith; Brigitte L Kieffer; Christopher J Evans
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

4.  Deciphering biased-agonism complexity reveals a new active AT1 receptor entity.

Authors:  Aude Saulière; Morgane Bellot; Hervé Paris; Colette Denis; Frédéric Finana; Jonas T Hansen; Marie-Françoise Altié; Marie-Hélène Seguelas; Atul Pathak; Jakob L Hansen; Jean-Michel Sénard; Céline Galés
Journal:  Nat Chem Biol       Date:  2012-05-27       Impact factor: 15.040

Review 5.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 6.  Microbial and animal rhodopsins: structures, functions, and molecular mechanisms.

Authors:  Oliver P Ernst; David T Lodowski; Marcus Elstner; Peter Hegemann; Leonid S Brown; Hideki Kandori
Journal:  Chem Rev       Date:  2013-12-23       Impact factor: 60.622

7.  Membrane modulates affinity for calcium ion to create an apparent cooperative binding response by annexin a5.

Authors:  Jacob W Gauer; Kristofer J Knutson; Samantha R Jaworski; Anne M Rice; Anika M Rannikko; Barry R Lentz; Anne Hinderliter
Journal:  Biophys J       Date:  2013-06-04       Impact factor: 4.033

Review 8.  Novel pathways in gonadotropin receptor signaling and biased agonism.

Authors:  Alfredo Ulloa-Aguirre; Pascale Crépieux; Anne Poupon; Marie-Christine Maurel; Eric Reiter
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

9.  Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL).

Authors:  Elisa Alvarez-Curto; Rudi Prihandoko; Christofer S Tautermann; Jurriaan M Zwier; John D Pediani; Martin J Lohse; Carsten Hoffmann; Andrew B Tobin; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2011-08-31       Impact factor: 4.436

10.  Retinal Flips the Script.

Authors:  Edward Lyman
Journal:  Biophys J       Date:  2015-06-16       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.